Trial Profile
Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Ibutamoren (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 03 Mar 2017 Results published in the Nephrology Dialysis Transplantation
- 06 Jun 2014 New trial record